DiaSorin Investor Relations Material
Latest events
Q2 2025
DiaSorin
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from DiaSorin S.p.A.
Access all reports
DiaSorin S.p.A. develops and manufactures diagnostic tests and systems for use in clinical laboratories. The company provides immunodiagnostic and molecular diagnostic solutions for detecting infectious diseases, hormones, and oncology markers. It serves healthcare providers and laboratories worldwide. The company is headquartered in Saluggia, Italy, and its shares are listed on the BIT.
Key slides for DiaSorin S.p.A.
Q2 2025
DiaSorin S.p.A.
Q1 2025
DiaSorin S.p.A.
Latest articles
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
Ticker symbol
DIA
Country
🇮🇹 Italy